Table 4.
Model I | Model II | Model III | ||||
---|---|---|---|---|---|---|
βa (SE) | P Value | βa (SE) | P Value | βa (SE) | P Value | |
Systolic blood pressure | ||||||
Baseline logCK | 4.9 (3.2) | .1 | 5.0 (3.2) | .1 | 3.1 (3.2) | .3 |
Physical activity | – | – | −1.0 (2.3) | .7 | −0.7 (2.2) | .8 |
Body mass index | – | – | – | – | 1.1 (0.3) | <.0001 |
Persistent high CK | 2.6 (2.1) | .2 | 2.6 (2.1) | .2 | 1.6 (2.1) | .4 |
Physical activity | – | – | −0.9 (2.3) | .7 | −0.6 (2.2) | .8 |
Body mass index | – | – | – | – | 1.2 (0.3) | <.0001 |
Diastolic blood pressure | ||||||
Baseline logCK | 3.3 (1.8) | .07 | 3.2 (1.8) | .07 | 2.6 (1.8) | .15 |
Physical activity | – | – | 0.3 (1.3) | .8 | 0.4 (1.2) | .7 |
Body mass index | – | – | – | – | 0.4 (0.2) | .01 |
Persistent high CK | 2.2 (1.2) | .06 | 2.1 (1.2) | .07 | 1.8 (1.2) | .1 |
Physical activity | – | – | 0.3 (1.3) | .8 | 0.4 (1.2) | .7 |
Body mass index | – | – | – | – | 0.4 (0.2) | .009 |
ORb (95% CI) | P Value | ORb (95% CI) | P Value | OR (95% CI) | P Value | |
Hypertension | ||||||
Baseline logCK | 2.2 (0.9–5.1) | .06 | 2.3 (1.0–5.3) | .06 | 1.9 (0.8–4.5) | .2 |
Physical activity | – | – | 0.9 (0.5–1.6) | .7 | 0.9 (0.5–1.6) | .7 |
Body mass index | – | – | – | – | 1.2 (1.1–1.3) | .0002 |
Persistent high CK | 1.7 (1.0–3.1) | .05 | 1.8 (1.0–3.1) | .048 | 1.6 (0.9–2.8) | .1 |
Physical activity | – | – | 0.9 (0.5–1.6) | .7 | 0.9 (0.5–1.6) | .7 |
Body mass index | – | – | – | – | 1.2 (1.1–1.3) | .0002 |
Abbreviations: CI, confidence interval; OR, odds ratio. Model I was adjusted for age and sex. Model II was adjusted for age, sex, and physical activity. Model III was additionally adjusted for BMI. aValues are regression coefficients (SE) expressed in mm Hg for a 1‐unit change in logCK, physical activity or body mass index (BMI), or for having persistent high creatine kinase (CK). bOdds for hypertension for a 1‐unit change in logCK, physical activity or BMI, or for having persistent high CK.